Elicio Therapeutics Files Q1 2025 10-Q
Ticker: ELTX · Form: 10-Q · Filed: May 13, 2025 · CIK: 1601485
| Field | Detail |
|---|---|
| Company | Elicio Therapeutics, Inc. (ELTX) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Elicio Therapeutics (formerly Angion Biomedica) filed its Q1 2025 10-Q. Financials and operations update.
AI Summary
Elicio Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Angion Biomedica Corp., is in the pharmaceutical preparations industry. Its principal executive offices are located at 451 D Street, 5th Floor, Boston, MA.
Why It Matters
This filing provides investors with an update on Elicio Therapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing financial and operational updates.
Key Numbers
- 20250331 — Period End Date (The filing covers the financial period ending March 31, 2025.)
- 20250513 — Filing Date (The 10-Q was filed on May 13, 2025.)
Key Players & Entities
- Elicio Therapeutics, Inc. (company) — Filer
- Angion Biomedica Corp. (company) — Former company name
- 451 D Street, 5th Floor, Boston, MA 02210 (location) — Business and mail address
- 20250331 (date) — Period of report
FAQ
What was Elicio Therapeutics' former company name?
Elicio Therapeutics, Inc. was formerly known as Angion Biomedica Corp.
What is the business address of Elicio Therapeutics?
The business address is 451 D Street, 5th Floor, Boston, MA 02210.
For what period is this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filed?
This 10-Q was filed on May 13, 2025.
What is Elicio Therapeutics' Standard Industrial Classification code?
Elicio Therapeutics' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Elicio Therapeutics, Inc. (ELTX).